BrickBio is a biotechnology company revolutionizing protein engineering with its site-specific conjugation platform. Utilizing technology developed by Dr. Abhishek Chatterjee, the company enables the incorporation of synthetic amino acids into proteins, creating novel biotherapeutics and antibody-drug conjugates. This precision engineering unlocks new possibilities for treating complex diseases.
